Boswellia Serrata – An Overlooked Joint Remedy

*Boswellia serrata*, commonly referred to as Indian frankincense, represents a species of resin-producing tree within the Burseraceae family, indigenous to the northern and northeastern regions of Africa, though extensively cultivated in the climatic conditions of India and the Arabian Peninsula. Its distinctive fruits, exhibiting a texture reminiscent of a blend of oily gum and dried raisins, are characterized by a delicate brownish-yellow hue. The genus name derives from the unique resin—known colloquially as olibanum—which has historically served both as ceremonial incense in religious practices and as a fragrant component in perfumery. Notably, *Boswellia serrata* synthesizes boswellic acids, a class of triterpenoid compounds with documented bioactive properties. Within the framework of India’s traditional Ayurvedic medicine, this plant occupies a pivotal position in the management of inflammatory musculoskeletal disorders, including spinal pain syndromes. Empirical evidence further suggests that olibanum demonstrates expectorant, antiseptic, anxiolytic, and neuroprotective effects. In Ayurvedic clinical practice, preparations derived from *Boswellia serrata* are regarded as efficacious adjunctive therapies for rheumatic diseases [1].

Boswellia serrata, commonly referred to as Indian frankincense, has been utilized for centuries in Ayurvedic medicine and has gained scientific validation through numerous clinical trials for its multifaceted therapeutic properties. The resin olibanum, derived from this tree, demonstrates a broad spectrum of health benefits, including: **analgesic** – effectively alleviates pain of various etiologies; **anti-inflammatory** – inhibits the synthesis of pro-inflammatory cytokines (e.g., IL-1, IL-6, TNF-α), making it a valuable adjunct in managing autoimmune conditions such as rheumatoid arthritis and Crohn’s disease; **anticancer** – preclinical and clinical evidence suggests potential efficacy in oncology, particularly for aggressive malignancies like pancreatic adenocarcinoma; **regenerative** – supports the repair of soft and cartilaginous tissues, which is particularly beneficial for athletes and individuals subjected to physical overuse; **anti-aging** – enhances skin elasticity and mitigates signs of photoaging; **anti-allergic** – attenuates symptoms of bronchial asthma and allergic responses; **antimicrobial** – exhibits bactericidal and fungicidal properties, useful in dermatological applications. Furthermore, its synergistic combination with curcumin amplifies its anti-inflammatory and antioxidant effects, as substantiated by randomized controlled trials with placebo groups.

Commercially available high-potency dietary supplements feature standardized resin extract from *Boswellia serrata*, with boswellic acids as the primary bioactive compounds (typically standardized to 60% concentration). Recognized for its anti-inflammatory properties and joint-supportive benefits, the therapeutic dosage of this extract is conventionally prescribed at 300–400 milligrams per serving, administered two to three times daily. Reference: citation [1].

The extract derived from Indian frankincense (Boswellia serrata), commercially available in oil form, along with olibanum resin, exhibits emmenagogue properties—meaning it promotes menstrual flow—while simultaneously elevating respiratory rate and enhancing diuresis, the daily urinary excretion process mediated by the kidneys. Consequently, these preparations are strongly discouraged for individuals experiencing heavy menstrual bleeding, irregular menstrual cycles, or those diagnosed with respiratory or renal impairments. Particular caution is advised for pregnant women, as the active compounds may induce heightened blood circulation within the uterine and pelvic regions, potentially resulting in premature termination of pregnancy under the most adverse conditions. Furthermore, there exists a documented, albeit infrequent, risk of pharmacological interactions with nonsteroidal anti-inflammatory drugs (NSAIDs), including acetylsalicylic acid and ibuprofen, necessitating personalized medical consultation prior to concurrent use.